Delivery Order SPE2DB24D1205-SPE2DB25FCTAD

Award Date 1/14/25
Potential Completion Date 2/5/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORGOVYX 120 MG TABLET, a medical product, with a ceiling value of $2,771.04 and an ultimate completion date of April 9, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORGOVYX 120 MG TABLET. The contract has a ceiling value of $1,329.89 and a period of performance through November 7, 2024. This is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,375.85, is for the supply of ORGOVYX 120 MG TABLET medical products. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ORGOVYX 120 MG TABLET. The contract has a firm fixed price of $2,659.78 and is not set aside for any small business program. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ORGOVYX 120 MG Tablet, a pharmaceutical product, with a firm fixed price ceiling of $1,329.89 and a completion date of October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, with a ceiling value of $1,375.85 and a period of performance through January 28, 2025. The contract is a firm-fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical and medical supplies distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ORGOVYX 120 MG TABLET, a prescription medication, at a ceiling value of $1,329.89. The contract has an ultimate completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, with a ceiling value of $1,375.85 and a performance period running through January 29, 2025. The contract is a firm fixed-price delivery order type, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,375.85, is for the supply of ORGOVYX 120 MG TABLET, a specialty pharmaceutical product. The contract has a period of performance through February 3, 2025 and is a Firm Fixed Price arrangement. There is no set-aside designation, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a $1,329.89 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of ORGOVYX 120 MG TABLET UU 30S pharmaceutical products. The award has an ultimate completion date of August 14, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTAD
    Delivery Order

This is a delivery order contract with the Defense Logistics Agency (DLA) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORGOVYX 120 MG TABLET prescription medication. The contract has a firm fixed price of $1,375.85 and a completion date of February 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive procurement vehicle for a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience and capabilities in pharmaceutical distribution and federal healthcare contracting make it a critical vendor for the DLA and other government agencies in meeting the medical supply needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:11 AM